Early Phase Oncology trials have evolved from simple safety checks to the most scientifically demanding stage of cancer drug development. In this episode of Accelerating Oncology – Inside the EPON Network, host Ken Morrison and guest Maria Garcia unpack why Phase 1 trials are no longer “entry-level” and why they require a specialized model for success.

Host: Ken Morrison, Fortrea Global Leader of Strategic Delivery and Growth in Oncology

Participant: Maria Garcia, Fortrea Medical Director